Targeting plasma cells in autoimmune diseases
Details
Publication Year 2004-06-07,Volume 199,Issue #11,Page 1451-1454
Journal Title
JOURNAL OF EXPERIMENTAL MEDICINE
Publication Type
Journal Article
Abstract
Antibodies specific for self-antigens mediate life-threatening pathology in several autoimmune diseases. Clearly the ability to target the plasma cells (PCs) producing the autoantibodies would be of great clinical benefit. Current immunosuppressive therapies are based on the premise that autoreactive PCs are short-lived and replenished from ongoing immune responses. However, recent results question this assumption and suggest that optimizing the treatment of severe autoimmune conditions will require a significant investment in elucidating the details of PC biology.
Publisher
ROCKEFELLER UNIV PRESS
Keywords
MEMORY B-CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTIBODY-FORMING-CELLS; PRIMARY IMMUNE-RESPONSE; BONE-MARROW; AFFINITY MATURATION; GERMINAL-CENTERS; SECRETING CELLS; MURINE LUPUS; DIFFERENTIATION
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2004-06-07 12:00:00
An error has occurred. This application may no longer respond until reloaded. Reload 🗙